Aeschengraben 27, 4051 Basel

Basel-Stadt

On the register mapOn the federal map (map.geo.admin.ch)

Active companies
12
In liquidation
0
Struck
3
Moved away
1

Companies at this address

2 of the 12 active companies are domiciled c/o someone at this address.

AllActiveIn liquidationStruck

BeOne Medicines AG

CHE-446.472.541 · Corporation · c/o BeOne Medicines I GmbH · registered May 27, 2025

BeOne Medicines I GmbH

CHE-151.848.099 · Limited liability company · registered Sep 5, 2017

BeOne Medicines International GmbH

CHE-166.213.277 · Limited liability company · registered Jun 12, 2020

BeOne Medicines Pharmaceuticals GmbH

CHE-370.901.453 · Limited liability company · registered Nov 3, 2020

Ernst & Young AG

CHE-105.932.265 · Corporation · registered Sep 28, 1998

EY Holding AG

CHE-115.043.409 · Corporation · registered Sep 3, 2009

Jungbunzlauer Holding AG

CHE-102.855.450 · Corporation · registered Dec 17, 1970

Jungbunzlauer International AG

CHE-102.570.119 · Corporation · registered Feb 1, 1991

Jungbunzlauer Suisse AG

CHE-115.981.207 · Corporation · registered Sep 10, 2010

Pensionskasse Ernst & Young

CHE-109.588.511 · Foundation · c/o EY Holding AG · registered Feb 28, 1961

Sumitomo Pharma Switzerland GmbH

CHE-330.400.601 · Limited liability company · registered Aug 17, 2016

Urovant Sciences GmbH

CHE-371.425.998 · Limited liability company · registered Nov 23, 2016

ATAG Ernst & Young Holding AG

CHE-100.995.436 · Corporation · Struck · registered Nov 6, 1998

BeOne Medicines II GmbH

CHE-371.344.259 · Limited liability company · Struck · registered Nov 1, 2024

Immobiliengesellschaft St. Alban-Vorstadt 90/92 AG

CHE-101.944.097 · Corporation · Struck

Formerly at this address

Companies whose gazette notices printed this address before they moved (notices since 2018).

Galapagos GmbH

CHE-388.581.566 · Jul 19, 2021 to Mar 10, 2025

Records naming this address

Building applications, SHAB proceedings, gazette notices and IP titles that print this address for one of their parties.

((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Jun 25, 2026

CANCER HAS NO BORDERS. NEITHER DO WE

Trademark · BeOne Medicines I GmbH (holder) · Sep 1, 2025

DGRYDA

Trademark · BeOne Medicines I GmbH (holder) · Jun 6, 2025

CYDACVI

Trademark · BeOne Medicines I GmbH (holder) · Jun 6, 2025

TAGDAC

Trademark · BeOne Medicines I GmbH (holder) · Jun 6, 2025

BeOne talk about it Cancer and Mental Health ((fig.))

Trademark · BeOne Medicines I GmbH (holder) · May 7, 2025

BEQALZI

Trademark · BeOne Medicines I GmbH (holder) · Apr 30, 2025

BeOn ((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Nov 13, 2024

BeOne Medicines

Trademark · BeOne Medicines I GmbH (holder) · Oct 22, 2024

BeOne

Trademark · BeOne Medicines I GmbH (holder) · Oct 22, 2024

((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Oct 13, 2024

((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Oct 13, 2024

((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Oct 13, 2024

BYCENRO

Trademark · BeiGene Switzerland GmbH (holder) · Mar 7, 2024

SONBYZO

Trademark · BeOne Medicines I GmbH (holder) · Mar 7, 2024

SONBAXTI

Trademark · BeOne Medicines I GmbH (holder) · Mar 7, 2024

BYCELTEV

Trademark · BeOne Medicines I GmbH (holder) · Mar 7, 2024

Schuldenruf infolge Fusion nach FusG Altavant Sciences GmbH mit Sumitomo Pharma Switzerland GmbH

SHAB proceeding · Sumitomo Pharma Switzerland GmbH (acquiring) · Dec 14, 2023

Schuldenruf infolge Fusion nach FusG Enzyvant Therapeutics GmbH mit Sumitomo Pharma Switzerland GmbH

SHAB proceeding · Sumitomo Pharma Switzerland GmbH (acquiring) · Dec 14, 2023

Schuldenruf infolge Fusion nach FusG Enzyvant Therapeutics GmbH mit Sumitomo Pharma Switzerland GmbH

SHAB proceeding · Sumitomo Pharma Switzerland GmbH (acquiring) · Dec 13, 2023

Schuldenruf infolge Fusion nach FusG Altavant Sciences GmbH mit Sumitomo Pharma Switzerland GmbH

SHAB proceeding · Sumitomo Pharma Switzerland GmbH (acquiring) · Dec 13, 2023

Schuldenruf infolge Fusion nach FusG Enzyvant Therapeutics GmbH mit Sumitomo Pharma Switzerland GmbH

SHAB proceeding · Sumitomo Pharma Switzerland GmbH (acquiring) · Dec 12, 2023

Schuldenruf infolge Fusion nach FusG Altavant Sciences GmbH mit Sumitomo Pharma Switzerland GmbH

SHAB proceeding · Sumitomo Pharma Switzerland GmbH (acquiring) · Dec 12, 2023

BeiMedPlus ((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Sep 4, 2023

BeiMedPlus

Trademark · BeOne Medicines I GmbH (holder) · Sep 4, 2023

VYOTIG

Trademark · BeiGene Switzerland GmbH (holder) · Apr 8, 2023

KYVANTIG

Trademark · BeiGene Switzerland GmbH (holder) · Apr 8, 2023

TIGVANZA

Trademark · BeiGene Switzerland GmbH (holder) · Apr 8, 2023

LINKTIGA

Trademark · BeOne Medicines I GmbH (holder) · Apr 8, 2023

OCIFTY

Trademark · BeiGene Switzerland GmbH (holder) · Apr 8, 2023

TEVIMBRA

Trademark · BeOne Medicines I GmbH (holder) · Mar 9, 2023

BeiGene talk about it Cancer and Mental Health ((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Feb 22, 2023

MYPEER

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Sep 12, 2022

EMDAUNZA

Trademark · BeiGene Switzerland GmbH (holder) · Mar 14, 2022

AFFYPERL

Trademark · BeiGene Switzerland GmbH (holder) · Mar 14, 2022

STENVIZY

Trademark · BeiGene Switzerland GmbH (holder) · Mar 14, 2022

OKPERLA

Trademark · BeiGene Switzerland GmbH (holder) · Mar 14, 2022

3-[(1H-PYRAZOL-4-YL)OXY]PYRAZIN-2-AMIN-VERBINDUNGEN ALS HPK1-INHIBITOR UND VERWENDUNG DAVON

Patent · BeOne Medicines I GmbH (holder) · Sep 29, 2021

((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Sep 10, 2021

BeiGene ((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Sep 10, 2021

TYK-2-INHIBITOR

Patent · BeOne Medicines I GmbH (holder) · Jun 21, 2021

((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Jun 14, 2021

((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Jun 14, 2021

VERFAHREN ZUR BEHANDLUNG VON DLBCL UNTER VERWENDUNG VON BTK-INHIBITOREN UND KOMBINATIONEN DAVON

Patent · Beigene Switzerland GmbH (holder) · Feb 25, 2021

GUIDEPSA

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 26, 2020

ONJAXY

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 26, 2020

JEPSAGO

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 26, 2020

BCL-2-INHIBITOREN

Patent · BeOne Medicines I GmbH (holder) · Apr 29, 2019

Brukinsa ((fig.))

Trademark · BeOne Medicines I GmbH (holder) · Mar 20, 2019

FORTELUMA

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 26, 2019

ONRELGO

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 6, 2019

GUARDERO

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 6, 2019

ORVONCE

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 6, 2019

RELHIBIT

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Feb 6, 2019

MYTROVIA

Trademark · Myovant Sciences GmbH (holder) · Aug 27, 2018

TRUFEMZIA

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Aug 27, 2018

MYCOURELLE

Trademark · Myovant Sciences GmbH (holder) · Aug 27, 2018

FEMALE FORWARD

Trademark · Sumitomo Pharma Switzerland GmbH (holder) · Aug 22, 2018

MYOVANT

Trademark · Myovant Sciences GmbH (holder) · Jul 13, 2018

MYOVANT SCIENCES ((fig.))

Trademark · Myovant Sciences GmbH (holder) · Jul 11, 2018

VERFAHREN ZUR BEHANDLUNG VON GEBÄRMUTTERMYOMEN UND ENDOMETRIOSE

Patent · Sumitomo Pharma Switzerland GmbH (holder) · Sep 29, 2017

ANTI-TIM-3-ANTIKÖRPER UND VERWENDUNG DAVON

Patent · BeiGene Switzerland GmbH (holder) · Aug 25, 2017

KOMBINATION VON ZANUBRUTINIB MIT EINEM ANTI-CD20 ODER ANTI-PD-1 ANTIKÖRPER ZUR VERWENDUNG IN DER BEHANDLUNG VON KREBS

Patent · BeOne Medicines I GmbH (holder) · Aug 18, 2017

KRISTALLINE FORM VON ((S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-A]PYRIMIDIN-3-CARBOXAMID, HERSTELLUNG UND VERWENDUNGEN DAVON

Patent · BeOne Medicines I GmbH (holder) · Aug 15, 2017

KONDENSIERTE TRICYCLISCHE HARNSTOFFVERBINDUNGEN ALS RAF-KINASE- UND/ODER RAF-KINASE-DIMER-HEMMER

Patent · BeOne Medicines I GmbH (holder) · Jun 27, 2014

KONDENSIERTE HETEROCYCLISCHE VERBINDUNGEN ALS PROTEINKINASEHEMMER

Patent · BeOne Medicines I GmbH (holder) · Apr 22, 2014

ANTI-PD1-ANTIKÖRPER SOWIE VERWENDUNG DAVON IN THERAPEUTIKA UND DIAGNOSTIKA

Patent · BeOne Medicines I GmbH (holder) · Sep 13, 2013

KONDENSIERTE TRICYCLISCHE VERBINDUNGEN ALS RAF-KINASEINHIBITOREN

Patent · BeOne Medicines I GmbH (holder) · Dec 31, 2011

Nearby

Addresses within 250 m with companies, lawyers or building applications, nearest first.

Aeschengraben 29, 4051 Basel

40 m · Companies: 86 · Lawyers: 1

Aeschengraben 21, 4051 Basel

41 m · Companies: 11

Parkweg 21, 4051 Basel

72 m · Companies: 1

Parkweg 25, 4051 Basel

73 m · Companies: 1

Parkweg 35, 4051 Basel

106 m · Companies: 6

Aeschengraben 15, 4051 Basel

116 m · Companies: 1

Gartenstrasse 112, 4052 Basel

117 m · Companies: 1

Gartenstrasse 118, 4052 Basel

123 m · Companies: 1

Aeschengraben 26, 4051 Basel

124 m · Companies: 4

Gartenstrasse 93, 4052 Basel

128 m · Companies: 4